Cargando…
SARS-CoV-2 RBD Conjugated to Polyglucin, Spermidine, and dsRNA Elicits a Strong Immune Response in Mice
Despite the rapid development and approval of several COVID vaccines based on the full-length spike protein, there is a need for safe, potent, and high-volume vaccines. Considering the predominance of the production of neutralizing antibodies targeting the receptor-binding domain (RBD) of S-protein...
Autores principales: | Volosnikova, Ekaterina A., Merkuleva, Iuliia A., Esina, Tatiana I., Shcherbakov, Dmitry N., Borgoyakova, Mariya B., Isaeva, Anastasiya A., Nesmeyanova, Valentina S., Volkova, Natalia V., Belenkaya, Svetlana V., Zaykovskaya, Anna V., Pyankov, Oleg V., Starostina, Ekaterina V., Zadorozhny, Alexey M., Zaitsev, Boris N., Karpenko, Larisa I., Ilyichev, Alexander A., Danilenko, Elena D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146165/ https://www.ncbi.nlm.nih.gov/pubmed/37112720 http://dx.doi.org/10.3390/vaccines11040808 |
Ejemplares similares
-
Delivery of mRNA Vaccine against SARS-CoV-2 Using a Polyglucin:Spermidine Conjugate
por: Karpenko, Larisa I., et al.
Publicado: (2021) -
Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice
por: Borgoyakova, Mariya B., et al.
Publicado: (2022) -
Comparative Immunogenicity of the Recombinant Receptor-Binding Domain of Protein S SARS-CoV-2 Obtained in Prokaryotic and Mammalian Expression Systems
por: Merkuleva, Iuliia A., et al.
Publicado: (2022) -
Immunogenicity of the DNA/Protein Combined Vaccine against COVID-19
por: Borgoyakova, M. B., et al.
Publicado: (2023) -
Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines?
por: Merkuleva, Iuliia A., et al.
Publicado: (2022)